Fats and factors: Lipid profiles associate with personality factors and suicidal history in bipolar subjects

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Evans, Simon J ^a   Prossin, Alan R ^a   Harrington, Gloria J ^a   Kamali, Masoud ^a   Ellingrod, Vicki L ^b   Burant, Charles F ^c   McInnis, Melvin G ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE 2; ARACHIDONIC ACID; ARIPIPRAZOLE; CLOZAPINE; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLENIC ACID; OLANZAPINE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; OXYGENASE; PALIPERIDONE; QUETIAPINE; RISPERIDONE; UNCLASSIFIED DRUG; ZIPRASIDONE; LIPID;

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; MALE; PERSONALITY; QUANTITATIVE ANALYSIS; RISK FACTOR; STRUCTURED INTERVIEW; SUICIDAL BEHAVIOR; SUICIDE; SUICIDE ATTEMPT; BIOSYNTHESIS; BLOOD; EXTRAVERSION; MIDDLE AGED; PSYCHOLOGICAL ASPECT;

ADULT; BIOSYNTHETIC PATHWAYS; BIPOLAR DISORDER; EXTRAVERSION (PSYCHOLOGY); FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; PERSONALITY; RISK FACTORS; SUICIDE; SUICIDE, ATTEMPTED; YOUNG ADULT;

EID: 84855856940     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029297     Document Type: Article

References (28)

1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, et al. (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62: 593-602.
2. Novick DM, Swartz HA, Frank E, (2010) Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence. Bipolar Disord 12: 1-9.
3. Gitlin M, (2006) Treatment-resistant bipolar disorder. Mol Psychiatry 11: 227-240.
4. Huan M, Hamazaki K, Sun Y, Itomura M, Liu H, et al. (2004) Suicide attempt and n-3 fatty acid levels in red blood cells: a case control study in China. Biol Psychiatry 56: 490-496.
5. De Vriese SR, Christophe AB, Maes M, (2004) In humans, the seasonal variation in poly-unsaturated fatty acids is related to the seasonal variation in violent suicide and serotonergic markers of violent suicide. Prostaglandins Leukot Essent Fatty Acids 71: 13-18.
6. Hibbeln JR, Umhau JC, Linnoila M, George DT, Ragan PW, et al. (1998) A replication study of violent and nonviolent subjects: cerebrospinal fluid metabolites of serotonin and dopamine are predicted by plasma essential fatty acids. Biol Psychiatry 44: 243-249.
7. Turnbull T, Cullen-Drill M, Smaldone A, (2008) Efficacy of n-3 fatty acid supplementation on improvement of bipolar symptoms: a systematic review. Arch Psychiatr Nurs 22: 305-311.
8. Hibbeln JR, Nieminen LR, Blasbalg TL, Riggs JA, Lands WE, (2006) Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am J Clin Nutr 83: 1483S-1493S.
9. Chalon S, (2006) N-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids 75: 259-269.
10. Rapoport SI, Basselin M, Kim HW, Rao JS, (2009) Bipolar disorder and mechanisms of action of mood stabilizers. Brain Res Rev 61: 185-209.
11. Lee HJ, Rao JS, Chang L, Rapoport SI, Kim HW, (2009) Chronic imipramine but not bupropion increases arachidonic acid signaling in rat brain: is this related to 'switching' in bipolar disorder? Mol Psychiatry 15: 602-614.
12. Arterburn LM, Hall EB, Oken H, (2006) Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 83: 1467S-1476S.
13. Glaser C, Heinrich J, Koletzko B, (2010) Role of FADS1 and FADS2 polymorphisms in polyunsaturated fatty acid metabolism. Metabolism 59: 993-999.
14. Gawrisch K, Soubias O, Mihailescu M, (2008) Insights from biophysical studies on the role of polyunsaturated fatty acids for function of G-protein coupled membrane receptors. Prostaglandins Leukot Essent Fatty Acids 79: 131-134.
15. Kim B, Joo YH, Kim SY, Lim JH, Kim EO, (2011) Personality traits and affective morbidity in patients with bipolar I disorder: the five-factor model perspective. Psychiatry Res 185: 135-140.
16. Brezo J, Paris J, Turecki G, (2006) Personality traits as correlates of suicidal ideation, suicide attempts, and suicide completions: a systematic review. Acta Psychiatr Scand 113: 180-206.
17. Janowsky DS, (2001) Introversion and extroversion: implications for depression and suicidality. Curr Psychiatry Rep 3: 444-450.
18. McCann SJ, (2010) Suicide, big five personality factors, and depression at the American state level. Arch Suicide Res 14: 368-374.
19. Hibbeln JR, (2009) Depression, suicide and deficiencies of n-3 essential fatty acids in modern diets. World Rev Nutr Diet 99: 17-30.
20. Barnett JH, Huang J, Perlis RH, Young MM, Rosenbaum JF, et al. (2010) Personality and bipolar disorder: dissecting state and trait associations between mood and personality. Psychol Med pp. 1-12.
21. Allen MH, Chessick CA, Miklowitz DJ, Goldberg JF, Wisniewski SR, et al. (2005) Contributors to suicidal ideation among bipolar patients with and without a history of suicide attempts. Suicide Life Threat Behav 35: 671-680.
22. De Berardis D, Conti CM, Serroni N, Moschetta FS, Carano A, et al. (2009) The role of cholesterol levels in mood disorders and suicide. J Biol Regul Homeost Agents 23: 133-140.
23. Liu Y, McNamara RK, (2011) Elevated Delta-6 desaturase (FADS2) gene expression in the prefrontal cortex of patients with bipolar disorder. J Psychiatr Res 45: 269-272.
24. Ellingrod VL, Taylor SF, Dalack G, Grove TB, Bly MJ, et al. (2011) Risk Factors Associated with Metabolic Syndrome in Bipolar and Schizophrenia. J Clin Psychopharm In Review.
25. Bligh EG, Dyer WJ, (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917.
26. Costa PT, McCrae RR, (1992) NEO PI-R professional manual Odessa, FL Psychological Assessment Resources, Inc.
27. Nurnberger JI Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, et al. (1994) Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 51: 849-859; discussion 863-844.
28. Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho BC, (2010) Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry 67: 255-262.